neodisher SBX
Country: Ingilterra
Lingwa: Ingliż
Sors: DrWeigert
Fuljett ta 'informazzjoni
(PIL)
22-09-2017
Karatteristiċi tal-prodott
(SPC)
22-09-2017
Disponibbli minn:
Dr. Weigert
Fuljett ta 'informazzjoni
Date revised: 06.10.2016
Print date: 26.05.17
3 / GB- 800069-013-01
Version: 3 / GB
Replaces Version: 2 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SBX
Page 1(7)
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
neodisher SBX
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
USE OF THE SUBSTANCE/PREPARATION
Washing and cleaning products (including solvent based products)
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
ADDRESS:
Chemische Fabrik Dr. Weigert GmbH & Co. KG
Mühlenhagen 85
D-20539 Hamburg
Telephone no.
+49 40 789 60 0
Fax no.
+49 40 789 60 120
www.drweigert.com
E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS:
sida@drweigert.de
1.4. EMERGENCY TELEPHONE NUMBER
GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352
323 3500
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
This product is not classified hazardous in accordance with Regulation
(EC) No 1272/2008.
2.2. LABEL ELEMENTS
LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008
HAZARD STATEMENTS
EUH210
Safety data sheet available on request.
2.3. OTHER HAZARDS
No special hazards have to be mentioned.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.2. MIXTURES
FURTHER INGREDIENTS
ALANINE, N,N-BIS(CARBOXYMETHYL)-, TRISODIUM SALT
CAS No.
164462-16-2
EINECS no.
423-270-5
Registration no.
01-0000016977-53
Concentration
>=
1
<
5
%
SECTION 4: FIRST AID MEASURES
4.1. DESCRIPTION OF FIRST AID MEASURES
GENERAL INFORMATION
Date revised: 06.10.2016
Print date: 26.05.17
3 / GB- 800069-013-01
Version: 3 / GB
Replaces Version: 2 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEODISHER SBX
Page 2(7)
In case of persistent symptoms consult doctor.
AFTER INHALATION
Ensure supply of fresh air. In the event of symptoms take medical
treatment.
AFTER SKIN CONTACT
In case of contact with skin wash off with warm water. Consult a
doctor if skin irritation persists.
AFTER
Aqra d-dokument sħiħ
Karatteristiċi tal-prodott
.
Aqra d-dokument sħiħ
